Dexamethasone intracanalicular insert for treating inflammation and pain after cataract surgery ID1154Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social careStatus:Awaiting developmentExpected publication date: TBC
Timrepigene emparvovec for treating choroideremia [ID3916]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ranibizumab port delivery system for treating diabetic macular oedema ID6137Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Botaretigene sparoparvovec for treating RPGR mutation-associated X-linked retinitis pigmentosa TS ID 10592Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Avacincaptad pegol for treating geographic atrophy caused by age-related macular degeneration [ID6401]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Inebilizumab for treating AQP4-IgG seropositive neuromyelitis optica spectrum disorders ID6430Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Polyhexanide eye drops for treating acanthamoeba keratitis in people 12 years and over [ID6497]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC